Follow
William Werbel MD PhD
Title
Cited by
Cited by
Year
Foot strike patterns and collision forces in habitually barefoot versus shod runners
DE Lieberman, M Venkadesan, WA Werbel, AI Daoud, S D’andrea, ...
Nature 463 (7280), 531-535, 2010
19562010
Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients
BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian, AB Massie, DL Segev, ...
Jama 325 (21), 2204-2206, 2021
9652021
Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients
BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian, AB Massie, DL Segev, ...
Jama 325 (17), 1784-1786, 2021
5552021
Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series
WA Werbel, BJ Boyarsky, MT Ou, AB Massie, AAR Tobian, ...
Annals of internal medicine 174 (9), 1330-1332, 2021
3402021
Early impact of COVID‐19 on transplant center practices and policies in the United States
BJ Boyarsky, T Po‐Yu Chiang, WA Werbel, CM Durand, RK Avery, ...
american Journal of Transplantation 20 (7), 1809-1818, 2020
2752020
Walking, running and the evolution of short toes in humans
C Rolian, DE Lieberman, J Hamill, JW Scott, W Werbel
Journal of Experimental Biology 212 (5), 713-721, 2009
2332009
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
BJ Boyarsky, JA Ruddy, CM Connolly, MT Ou, WA Werbel, ...
Annals of the rheumatic diseases 80 (8), 1098-1099, 2021
1852021
Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients
CX Qin, LW Moore, S Anjan, R Rahamimov, CD Sifri, NM Ali, MK Morales, ...
Transplantation 105 (11), e265-e266, 2021
1582021
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
JA Ruddy, CM Connolly, BJ Boyarsky, WA Werbel, L Christopher-Stine, ...
Annals of the rheumatic diseases 80 (10), 1351-1352, 2021
1262021
Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series
JL Alejo, J Mitchell, TPY Chiang, AT Abedon, BJ Boyarsky, RK Avery, ...
Transplantation 105 (12), e280-e281, 2021
1192021
Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two‐dose SARS–CoV‐2 messenger RNA vaccination
CM Connolly, JA Ruddy, BJ Boyarsky, I Barbur, WA Werbel, D Geetha, ...
Arthritis & Rheumatology 74 (1), 28-32, 2022
1142022
A third dose of SARS‐CoV‐2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
AH Karaba, X Zhu, T Liang, KH Wang, AG Rittenhouse, O Akinde, Y Eby, ...
American Journal of Transplantation 22 (4), 1253-1260, 2022
982022
Safety and reactogenicity of 2 doses of SARS-CoV-2 vaccination in solid organ transplant recipients
MT Ou, BJ Boyarsky, JD Motter, RS Greenberg, AT Teles, JA Ruddy, ...
Transplantation 105 (10), 2170-2174, 2021
892021
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
JA Ruddy, BJ Boyarsky, JR Bailey, AH Karaba, JM Garonzik-Wang, ...
Aids 35 (14), 2399-2401, 2021
822021
Safety of the first dose of SARS-CoV-2 vaccination in solid organ transplant recipients
BJ Boyarsky, MT Ou, RS Greenberg, AT Teles, WA Werbel, RK Avery, ...
Transplantation 105 (5), e56-e57, 2021
772021
Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic
BJ Boyarsky, WA Werbel, CM Durand, RK Avery, KR Jackson, ...
American Journal of Transplantation 20 (11), 3131-3139, 2020
742020
Antibody response to the Janssen COVID-19 vaccine in solid organ transplant recipients
BJ Boyarsky, TPY Chiang, MT Ou, WA Werbel, AB Massie, DL Segev, ...
Transplantation 105 (8), e82-e83, 2021
642021
Immunogenicity and reactogenicity after SARS-CoV-2 mRNA vaccination in kidney transplant recipients taking belatacept
MT Ou, BJ Boyarsky, TPY Chiang, S Bae, WA Werbel, RK Avery, ...
Transplantation 105 (9), 2119-2123, 2021
632021
Antibody response to severe acute respiratory syndrome‐coronavirus‐2 messenger RNA vaccines in liver transplant recipients
AT Strauss, AM Hallett, BJ Boyarsky, MT Ou, WA Werbel, RK Avery, ...
Liver Transplantation 27 (12), 1852-1856, 2021
622021
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
CM Connolly, JA Ruddy, BJ Boyarsky, RK Avery, WA Werbel, DL Segev, ...
Annals of the rheumatic diseases 80 (8), 1100-1101, 2021
622021
The system can't perform the operation now. Try again later.
Articles 1–20